Effect of Indomethacin on the Progression of Alzheimer's Disease
Status:
Completed
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is determine whether indomethacin is able to retard disease
progression in patients with mild to moderate Alzheimer's disease.
Phase:
Phase 3
Details
Lead Sponsor:
Radboud University
Collaborators:
American Health Assistance Foundation Netherlands Alzheimer Foundation Netherlands Brain Foundation